| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.095 | 0.0005 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0009 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |